Viking Therapeutics, Inc. SEC filings
Every EDGAR filing for Viking Therapeutics, Inc. (VKTX), newest first, with AI summaries and stories.
- Ticker
- VKTX
- CIK
- 1607678
- Sector
- Biotech and pharma
- Latest filing
- Sep 28
Next: earnings expected ~Oct 26 · 10-Q expected ~Oct 26 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KViking Therapeutics, Inc.VKTXLIVE ROUTINE424B5Viking Therapeutics, Inc.VKTXLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
ROUTINEFWPViking Therapeutics, Inc.VKTXLIVE ROUTINE305B2Viking Therapeutics, Inc.VKTXLIVE ROUTINE424B5Viking Therapeutics, Inc.VKTXLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
ROUTINE8-KViking Therapeutics, Inc.VKTXLIVE ROUTINE4Viking Therapeutics, Inc.VKTXLIVE 2 insider filings
Dorothy Elizabeth Kelly-Gemmell, insider filing for VKTX
Show all 2
- 4Insider filing for VKTX
- 3New insider at VKTX
Dorothy Elizabeth Kelly-Gemmell, reporting
ROUTINES-3ASRViking Therapeutics, Inc.VKTXLIVE ROUTINE4Viking Therapeutics, Inc.VKTXLIVE 3 insider filings
Brian Lian, insider filing for VKTX
Show all 3
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
Brian Lian, reporting
NOTABLE10-QViking Therapeutics, Inc.VKTXLIVE ROUTINE144Viking Therapeutics, Inc.VKTXLIVE 3 Form 144 notices
Brian Lian, planned sale of VKTX shares
Show all 3
- 144Planned insider sale of VKTX shares
- 144Planned insider sale of VKTX shares
- 144Planned insider sale of VKTX shares
Brian Lian, reporting
ROUTINE8-KViking Therapeutics, Inc.VKTXLIVE ROUTINE4Viking Therapeutics, Inc.VKTXLIVE 2 insider filings
Hubert C Chen, insider filing for VKTX
Show all 2
- 4Insider filing for VKTX
- 3New insider at VKTX
Hubert C Chen, reporting
ROUTINE8-KViking Therapeutics, Inc.VKTXLIVE ROUTINESCHEDULE 13GViking Therapeutics, Inc.VKTXLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
NOTABLE10-QViking Therapeutics, Inc.VKTXLIVE ROUTINE8-KViking Therapeutics, Inc.VKTXLIVE ROUTINEDEFA14AViking Therapeutics, Inc.VKTXLIVE ROUTINEARSViking Therapeutics, Inc.VKTXLIVE ROUTINEDEF 14AViking Therapeutics, Inc.VKTXLIVE ROUTINESCHEDULE 13G/AViking Therapeutics, Inc.VKTXLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE4Viking Therapeutics, Inc.VKTXLIVE Neil William Aubuchon, insider filing for VKTX
Neil William Aubuchon, reporting
NOTABLE10-KViking Therapeutics, Inc.VKTXLIVE ROUTINE8-KViking Therapeutics, Inc.VKTXLIVE ROUTINE4Viking Therapeutics, Inc.VKTXLIVE 2 insider filings
Neil William Aubuchon, insider filing for VKTX
Show all 2
- 4Insider filing for VKTX
- 3New insider at VKTX
Neil William Aubuchon, reporting
ROUTINE4Viking Therapeutics, Inc.VKTXLIVE 8 insider filings
Greg Zante, insider filing for VKTX
Show all 8
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
- 4Insider filing for VKTX
Greg Zante, reporting
ROUTINE144Viking Therapeutics, Inc.VKTXLIVE 3 Form 144 notices
Marianna Mancini, planned sale of VKTX shares
Show all 3
- 144Planned insider sale of VKTX shares
- 144Planned insider sale of VKTX shares
- 144Planned insider sale of VKTX shares
Marianna Mancini, reporting
ROUTINE144Viking Therapeutics, Inc.VKTXLIVE Matthew W Foehr, planned sale of VKTX shares
Matthew W Foehr, reporting
ROUTINESCHEDULE 13G/AViking Therapeutics, Inc.VKTXLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by